When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFNX - Pfenex not quite there with full U.S. approval of Forteo biosimilar
Pfenex Inc.
Pfenex (NYSEMKT:PFNX) announces that the FDA informed commercialization partner Alvogen Malta Operations Ltd. that it needs additional comparative use human factors data regarding PKF708, its biosimilar candidate to Eli Lilly's (NYSE:LLY) osteoporosis med Forteo (teriparatide injection), before it can determine therapeutic equivalence.
More news on: Pfenex Inc., Eli Lilly and Company, Healthcare stocks news,